Edition:
India

Revance Therapeutics Inc (RVNC.OQ)

RVNC.OQ on NASDAQ Stock Exchange Global Market

26.20USD
17 Aug 2018
Change (% chg)

$-0.10 (-0.38%)
Prev Close
$26.30
Open
$26.15
Day's High
$26.40
Day's Low
$26.05
Volume
43,522
Avg. Vol
72,145
52-wk High
$37.45
52-wk Low
$22.40

Select another date:

Wed, May 9 2018

BRIEF-Revance Reports Qtrly Loss Per Share $0.97

* REITERATES ITS FINANCIAL GUIDANCE PROVIDED IN JANUARY 2018 Source text for Eikon: Further company coverage:

Mylan teams up with Revance on biosimilar for Botox

NEW YORK Mylan NV on Wednesday struck a licensing agreement with Revance Therapeutics Inc to develop a biosimilar of Allergan Plc's blockbuster Botox wrinkle treatment.

CORRECTED-Mylan teams up with Revance on biosimilar for Botox

NEW YORK, Feb 28 Mylan NV on Wednesday struck a licensing agreement with Revance Therapeutics Inc to develop a biosimilar of Allergan Plc's blockbuster Botox wrinkle treatment.

BRIEF-Revance Reports Qtrly Net Loss Per Share Attributable To Common Stockholders $1.14

* REVANCE THERAPEUTICS INC - ‍REITERATES ITS FINANCIAL GUIDANCE PROVIDED IN JANUARY 2018​

BRIEF-Revance Therapeutics, Mylan Ireland Enter Collaboration Deal‍

* REVANCE THERAPEUTICS SAYS ‍CO, MYLAN IRELAND LIMITED ENTERED INTO COLLABORATION DEAL- SEC FILING​

Select another date: